Innomar unit acquires Cameron Stewart LifeScience (CSL), provider of copay cards
Copay cards and related financial support for patients (such as vouchers and reimbursement support) have become a standard part of the launch of many new pharmaceuticals, particularly specialty ones. Now, as part of an ongoing buildout of patient support services, Innomar Strategies (Oakville, ON), a unit of AmerisourceBergen Specialty Canada, has acquired CSL, also based in Oakville. “This partnership with Cameron Stewart is a natural extension of our integrated solutions and will enable us to deliver more comprehensive services to our clients, specifically within programs that use co-payment assistance, bridging to reimbursement, e-sampling and compassionate use,” said Guy Payette, president of Innomar, in a statement. “Together, our clients will benefit from our operational efficiencies, with advanced adherence monitoring, integrated data collection and reporting capabilities throughout the patient journey.”
CSL is said to be the first company to offer brand loyalty cards in Canada, and has assisted more than five million patients remain on therapy. It is the developer of the RxHelp.ca platform and RxHelp ONE card, two innovative service offerings used by patients and pharmacies that provide access to savings on more than 40 medications. Innomar provides services ranging from strategic consulting to full-service patient support programs with integrated nursing, pharmacy and specialty distribution services.
AmerisourceBergen had divested much of its Canadian distribution business in 2013, but retained ownership of its specialty distribution business. In 2014 it made a strategic investment in Innomar, expanding its warehousing capacity.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.